Enovis to Participate in Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis Corporation (NYSE: ENOV), a medical technology growth company, has announced its upcoming participation in three major investor conferences:
- Canaccord Genuity 45th Annual Growth Conference on August 13th at 8:30 a.m. ET
- Wells Fargo Healthcare Conference on September 3rd at 2:15 p.m. ET
- Baird 2025 Global Healthcare Conference on September 10th at 3:10 p.m. ET
Live audio webcasts and replays will be accessible through the Investors section of the company's website under Events and Presentations.
Details
News Market Reaction – ENOV
On Aug 8, the day this news came out, ENOV closed 0.28% below the previous close.
Data tracked by StockTitan Argus for the Aug 8 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
- Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13th at 8:30 a.m. Eastern Time.
- Wells Fargo Healthcare Conference on Wednesday, September 3rd at 2:15 p.m. Eastern Time.
- Baird 2025 Global Healthcare Conference on Wednesday, September 10th at 3:10 p.m. Eastern Time.
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.